METTL14 and pancreatic neoplasm: Kong et al.96validated that down‐regulation of METTL14 makes pancreatic cancer cells sensitive to cisplatin by accelerating apoptosis, and improves autophagy induced by cisplatin through the mTOR signaling‐dependent pathway.